CAV1 and gastric cancer: Wang et al. observed that silencing of caveolin-1 significantly reduces drug resistance of breast cancer cells (Wang et al., 2014), and Yuan et al. introduced the promoting effect of caveolin-1 in drug resistance of human gastric cancer cells (Yuan et al., 2013).